Clinical Study Results
What adverse reactions did the participants have?
The most common adverse reaction was a urinary tract infection.
The table below shows the most common adverse reactions in this study that
happened in at least 2 participants in either treatment group. There were other
adverse reactions, but these happened in fewer participants.
Most common adverse reactions
Dapagliflozin 10 mg Placebo
(Out of 160 (Out of 161
participants) participants)
Urinary tract infection 1.3% (2) 1.2% (2)
Frequent need to urinate 1.9% (3) 0.0% (0)
Frequent thirst 1.3% (2) 0.0% (0)
Gout, also known as
1.3% (2) 0.0% (0)
arthritis in the joints
Vaginal itching 1.3% (2) 0.0% (0)
Kidney damage 0.0% (0) 1.2% (2)
How has this study helped patients and
researchers?
The results presented here are from a single study. These results helped the
researchers learn how dapagliflozin affects the blood sugar levels in people with
type 2 diabetes who already have damaged kidneys.
Researchers look at the results of many studies to decide which treatments
work best and are safest. Other studies may provide new information or different
results. Always talk to a doctor before making any treatment changes.
Further clinical studies with dapagliflozin are planned.
7